Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention

Medicinal Research Reviews
Kap-Sun YeungNicholas A Meanwell

Abstract

A novel human coronavirus (CoV) has been identified as the etiological agent that caused the severe acute respiratory syndrome (SARS) outbreak in 2003. The spike (S) protein of this virus is a type I surface glycoprotein that mediates binding of the virus to the host receptor and the subsequent fusion between the viral and host membranes. Because of its critical role in viral entry, the S protein is an important target for the development of anti-SARS CoV therapeutics and prophylactics. This article reviews the structure and function of the SARS CoV S protein in the context of its role in virus entry. Topics that are discussed include: the interaction between the S1 domain of the SARS spike protein and the cellular receptor, angiotensin converting enzyme 2 (ACE2), and the structural features of the ectodomain of ACE2; the antigenic determinants presented by the S protein and the nature of neutralizing monoclonal antibodies that are elicited in vivo; the structure of the 4,3-hydrophobic heptad repeats HR1 and HR2 of the S2 domain and their interaction to form a six-helical bundle during the final stages of fusion. Opportunities for the design and development of anti-SARS agents based on the inhibition of receptor binding, the th...Continue Reading

References

Apr 13, 1999·Molecular Cell·K A BakerT S Jardetzky
Dec 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·X ZhaoP S Kim
Jun 8, 2001·Annual Review of Biochemistry·D M Eckert, P S Kim
Jun 21, 2002·Nature·Michael A CrackowerJosef M Penninger
Oct 3, 2002·Journal of the American Chemical Society·Natalie A DalesMichael A Patane
Feb 28, 2003·The Journal of Biological Chemistry·Lili HuangRobert C Ladner
May 6, 2003·Science·Marco A MarraRachel L Roper
Jun 5, 2003·The Journal of Clinical Investigation·Kathryn V Holmes
Jul 23, 2003·Biochimica Et Biophysica Acta·Stephen A GalloRobert Blumenthal
Sep 11, 2003·Journal of Medical Virology·M L NgA E Ling
Sep 27, 2003·Biochemical and Biophysical Research Communications·Ottavia SpigaNeri Niccolai
Nov 19, 2003·Current Opinion in Infectious Diseases·Andrew Davidson, Stuart Siddell
Dec 4, 2003·Biochemical and Biophysical Research Communications·Xiaodong XiaoDimiter S Dimitrov
Dec 13, 2003·The Journal of Biological Chemistry·Swee Kee WongMichael Farzan
Jan 13, 2004·Biochemical and Biophysical Research Communications·Ponraj PrabakaranDimiter S Dimitrov
Jan 15, 2004·The Journal of Infectious Diseases·Daniel R KuritzkesWilliam R Shanahan
Feb 3, 2004·The Journal of Biological Chemistry·Paul TowlerMichael W Pantoliano
Feb 10, 2004·Biochemical and Biophysical Research Communications·Peigang WangHongkui Deng
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jianhua SuiWayne A Marasco
Mar 5, 2004·The Journal of Biological Chemistry·Brian TripetRobert S Hodges
Mar 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Graham SimmonsPaul Bates
Mar 24, 2004·Nature Reviews. Microbiology·Konrad StadlerRino Rappuoli
May 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·Berend Jan BoschPeter J M Rottier
May 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Paolo IngallinellaAntonello Pessi
May 29, 2004·Trends in Pharmacological Sciences·Anthony J TurnerNigel M Hooper
Jun 2, 2004·Journal of Medical Virology·Zhang QinfenZhang Jingqiang
Jun 9, 2004·Biochemical and Biophysical Research Communications·Kehu YuanHongkui Deng
Jun 9, 2004·Biochemical and Biophysical Research Communications·Ronghong HuaGuangzhi Tong

❮ Previous
Next ❯

Citations

Oct 30, 2008·Virus Genes·Chi-Pang ChuckStephen Kwok-Wing Tsui
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Roberto RangelRenata Pasqualini
Apr 22, 2008·Biochimica Et Biophysica Acta·Ana J Pérez-BernáJosé Villalaín
Feb 14, 2020·Journal of Medical Virology·Lei Zhang, Yunhui Liu
Apr 21, 2020·Annals of Intensive Care·Lei LiDechang Chen
Jan 17, 2021·Microorganisms·Saman Fouladirad, Horacio Bach
Nov 13, 2020·Frontiers in Pharmacology·Md Farhad HossainMohamed M Abdel-Daim
Feb 23, 2021·Frontiers in Molecular Biosciences·Rajashri R Naik, Ashok K Shakya
Aug 17, 2021·Phytotherapy Research : PTR·Muhammad Ajmal ShahGaber El-Saber Batiha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.